Episode 245: Three studies you need to know about – so get a PREMIUM membership!
Submitted by JPM on Fri, 2014-06-27 22:14.
In episode 245, Mike and James PREMIUM the listeners with talk about three new studies. Aleglitazar a new drug that was supposed to help people with type 2 diabetes, how best to use delayed antibiotic prescribing and a trial that answers the question about population screening for high cardiovascular risk patients.
Show notes
1) AleCardio - aleglitazar